Ads
related to: macular degeneration stem cell transplant- Clinical Trial Data
View Clinical Trial Data On Safety
Of A DME Treatment
- Patient Financial Support
Help Your Patients Reduce Their
Financial Burden For Treatment
- Dosing Information
See The Dosing Options And Schedule
For A DME Treatment
- HCP Resources
Find HCP & Practice Resources
For Viewing Or Download
- Safety Information
Find ISI & Prescribing Info For A
Wet AMD And DME Treatment
- Mechanism Of Action
View The Proposed MOA For An FDA
Approved Therapy For nAMD & DME
- Clinical Trial Data
Search results
Results from the WOW.Com Content Network
Stem cell therapy for macular degeneration is the use of stem cells to heal, replace dead or damaged cells of the macula in the retina. Stem cell based therapies using bone marrow stem cells as well as retinal pigment epithelial transplantation are being studied. [1] A number of trials have occurred in humans with encouraging results.
Masayo Takahashi (高橋 政代, Takahashi Masayo, born June 23, 1961) is a Japanese medical physician, ophthalmologist and stem cell researcher.. Takahashi serves as a project research leader at the Riken Center for Developmental Biology in Kobe focusing on the clinical application of iPS Cell (induced Pluripotent Stem Cell) technology on macular degeneration.
A retinal implant is a visual prosthesis for restoration of sight to patients blinded by retinal degeneration. The system is meant to partially restore useful vision to those who have lost their photoreceptors due to retinal diseases such as retinitis pigmentosa (RP) or age-related macular degeneration (AMD).
The FDA approved two biosimilars for Eylea (aflibercept), a drug used to treat age-related macular degeneration, diabetic retinopathy and other eye conditions. Biosimilars Yesafili and Opuviz work ...
8.7% global prevalence in 2020 [2] Macular degeneration, also known as age-related macular degeneration ( AMD or ARMD ), is a medical condition which may result in blurred or no vision in the center of the visual field. [1] Early on there are often no symptoms. [1] Over time, however, some people experience a gradual worsening of vision that ...
Stem-cell therapy uses stem cells to treat or prevent a disease or condition. [1] As of 2016, the only established therapy using stem cells is hematopoietic stem cell transplantation. [2] This usually takes the form of a bone marrow transplantation, but the cells can also be derived from umbilical cord blood.
Ads
related to: macular degeneration stem cell transplant